慢性髓单细胞白血病BLAST和BLAST- mol风险模型的验证：Mayo-Humanitas合作项目，涉及1101例患者。

IF 9.9 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2025-09-25 DOI:10.1002/ajh.70080

Saubia Fathima,Ali Alsugair,Muhammad Yousuf,Priyansh Faldu,Clifford Csizmar,Merry Nakhleh,Abhishek A Mangaonkar,Animesh Pardanani,Luca Lanino,Alessia Campagna,Giulia Maggioni,Kaaren K Reichard,Rong He,Naseema Gangat,Mrinal M Patnaik,Matteo G Della Porta,Ayalew Tefferi

引用次数: 0

摘要

目前的研究在一个大型双中心国际队列中验证了BLAST和BLAST- mol风险模型的预测性能，该队列共有1101名新诊断的CMML患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Validation of BLAST and BLAST-Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo-Humanitas Collaborative Project Involving 1101 Patients.

The current study validates the predictive performance of the BLAST and BLAST-Mol risk models in a large two-center international cohort with a total of 1101 patients with newly diagnosed CMML.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.